A rally in drug stocks has driven the Dow and S&P 500 to record highs, showcasing resilience in healthcare despite economic challenges like a government shutdown.
Discover how the Trump-Pfizer agreement ignited a stock rally, boosting pharma stocks. Explore investment opportunities in $PFE, $MRNA, $JNJ, $GILD, and $ABBV amidst market uncertainties.
Explore the impact of emerging drug pricing policies on major pharmaceutical stocks like Pfizer, J&J, and Moderna. Stay informed to navigate market shifts effectively.
Explore how Trump's recent Truth Social posts impact Delta Airlines and pharmaceutical stocks. Key insights for investors on market trends and consumer behavior.
Explore Moderna's Q2 2025 financial report highlighting a net loss of $825M, cash decline, and deferred revenue growth. Investment recommendation: Hold.
Discover the latest 8-K filing by Moderna, Inc. (MRNA) on August 1, 2025. Learn about significant events impacting shareholders and stock performance.
Discover Moderna's latest 8-K filing, detailing significant corporate events and financial updates. Stay informed with structured data for enhanced analysis and transparency.
Explore Moderna's Q1 2025 financial performance, revealing key sales, losses, and strategic recommendations for investors amid evolving market dynamics.
Explore the latest 8-K report for Moderna, Inc. detailing significant corporate events as of May 1, 2025. Learn about stock performance, SEC compliance, and more.
Explore the current challenges in the biotech sector and discover promising companies like Moderna, Biogen, and Amgen. Learn how to navigate this volatile landscape for wise investment.
April brings unprecedented stock volatility as investors face huge swings. Key players like Tesla and Apple react to macroeconomic pressures, reshaping market dynamics.
Explore the challenges and opportunities in the biotech sector amid market turmoil. Learn about key players and strategic insights for informed investment decisions.